DIPEXIUM PHARMACEUTICALS
Dipexium Pharmaceuticals operates as a biopharmaceutical company that develops and commercializes, pexiganan, a small peptide anti-infective agent. It provides Locilex, a small peptide topical antibiotic for the treatment of mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus.
DIPEXIUM PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
2010-01-01
Address:
White Plains, New York, United States
Country:
United States
Website Url:
http://www.dipexiumpharmaceuticals.com
Total Employee:
11+
Status:
Closed
Contact:
914-949-3898
Total Funding:
6.93 M USD
Technology used in webpage:
Domain Not Resolving Amazon GoDaddy DNS GStatic Google Static Content AWS Global Accelerator
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:DPRX
Official Site Inspections
http://www.dipexiumpharmaceuticals.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
Loading ... 